Author:
Zhang Ying,Li Jiaxin,Li Yan,Wang Wei,Wang Daming,Ding Junli,Wang Licheng,Cheng Juan
Funder
Research Fund of Anhui Institute of translational medicine
Basic and Clinical Cooperative Research Promotion Program of Anhui Medical University
National Natural Science Foundation of China
Natural Science Foundation of Universities of Anhui Province
Natural Science Foundation of Anhui Province
Publisher
Springer Science and Business Media LLC
Reference54 articles.
1. Weerink MAS, Struys M, Hannivoort LN, Barends CRM, Absalom AR, Colin P (2017) Clinical pharmacokinetics and pharmacodynamics of Dexmedetomidine. Clin Pharmacokinet 56:893–913. https://doi.org/10.1007/s40262-017-0507-7
2. Link R, Daunt D, Barsh G, Chruscinski A, Kobilka B (1992) Cloning of two mouse genes encoding alpha 2-adrenergic receptor subtypes and identification of a single amino acid in the mouse alpha 2-C10 homolog responsible for an interspecies variation in antagonist binding. Mol Pharmacol 42:16–27
3. Wang CD, Buck MA, Fraser CM (1991) Site-directed mutagenesis of alpha 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists. Mol Pharmacol 40:168–179
4. Ramos BP, Arnsten AF (2007) Adrenergic pharmacology and cognition: focus on the prefrontal cortex. Pharmacol Ther 113:523–536. https://doi.org/10.1016/j.pharmthera.2006.11.006
5. Maletic V, Eramo A, Gwin K, Offord SJ, Duffy RA (2017) The role of Norepinephrine and its α-Adrenergic receptors in the pathophysiology and treatment of major depressive disorder and Schizophrenia: a systematic review. Front Psychiatry 8:42. https://doi.org/10.3389/fpsyt.2017.00042